Click followed the journey of the second UK patient to have the procedure at Hammersmith Hospital in London. Andrew, aged 72, is just one of eleven people across Europe who have the V-LAP as part of a European trial. The third UK patient will have the procedure at Birmingham’s Queen Elizabeth Hospital in April.
The implantable device has far reaching implications for the millions of patients suffering from heart disease worldwide. Since the pressure of the heart’s left atrium is the earliest and most accurate real-time indication of heart failure exacerbation, the feedback provided by the V-LAP will enable a significant improvement in ongoing management of these patients.
It will enable doctors to adjust the patient’s medication early enough, often remotely, and as a result avoid their condition worsening and a potential re-admission into hospital.
According to the British Heart Foundation, there are around 7.4 million people living with heart and circulatory diseases in the UK and 180 people will die from them every day. Around twice as many people are living with heart and circulatory diseases than with cancer and Alzheimer’s disease combined.
V-LAP has also been featured in national media including Daily Telegraph, Daily Mail, The Sun and Forbes.
You can view the BBC Click episode featuring Vectorious and its V-LAP technology here.